Influenza Vaccine Market By Vaccine Type (Trivalent Flu Vaccines and Quadrivalent Flu Vaccines); By Influenza Type (Seasonal, Pandemic, and Others); By Type (Live Attenuated Influenza Vaccine (LAIV), Inactivated Influenza Vaccine (IIV), and Recombinant Influenza Vaccine (RIV)); By Manufacturing Technology (Egg Based and Cell Based); By Packaging (Prefilled Needleless Syringes and Single Dose and Multi-Dose Vial); By Dosage Form (Intramuscular Injection, Intradermal Shot, and Nasal Spray); By Age Group (6 months to 4 Years, 4 Years to 18 Years, 18 Years to 49 Years, 49 Years to 65 Years, and More than 65 Years); By Distribution Channel (Doctors’ Offices, Healthcare Clinics, Retail Pharmacies, Hospitals, and Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029